The drug ceftriaxone is the main treatment for gonorrhoea so experts are concerned when infections fail to respond to it.

The UKHSA has released its annual STI data, with continuing concern over rising syphilis and drug-resistant gonorrhoea. Learn ...

Health chiefs have sounded the alarm over a "concerning jump" in hard-to-treat gonorrhoea cases, with more occurring in 2025 ...

Syphilis cases in England continue to rise. New data from the UK Health Security Agency (UKHSA) shows that syphilis diagnoses ...

where the prevalence of ceftriaxone resistance is high. Elsewhere, among people in England, early-stage syphilis diagnoses rose 1.7%, from 9,375 in 2023 to 9,535 in 2024. open image in gallery The ...

New cases of the sexually transmitted infection syphilis have risen again in England, continuing a trend dating back to the ...

But the overall figure for syphilis, including what is called late ... longer respond to the first-line treatment, the antibiotic ceftriaxone. The numbers themselves remain low, with 14 cases ...